Sign in or Register   Sign in or Register
  |  

Mouse Anti-MYH7 Recombinant Antibody (CBYY-C2698) (CBMAB-C4139-YY)

This product is mouse antibody that recognizes MYH7. The antibody CBYY-C2698 can be used for immunoassay techniques such as: WB
See all MYH7 antibodies

Summary

Host Animal
Mouse
Specificity
Dog, Human, Monkey, Mouse, Pig, Rabbit, Rat, Sheep
Clone
CBYY-C2698
Application
WB

Basic Information

Immunogen
Recombinant human caspase-7 full length protein
Specificity
Dog, Human, Monkey, Mouse, Pig, Rabbit, Rat, Sheep
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Protein G purified
Preservative
PBS, pH 7.2, 0.1mM PMSF
Concentration
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
myosin heavy chain 7
Entrez Gene ID
Human4625
Mouse140781
Rat29557
Monkey100428939
Dog403807
Pig396860
Rabbit100101566
Sheep442995
UniProt ID
HumanP12883
MouseQ91Z83
RatP02564
MonkeyF6ZIH3
DogP49824
PigP79293
RabbitP04461
SheepW5QDF5
Alternative Names
CPR, CYPOR, P450R
Function
Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle.
Biological Process
Adult heart development Source: HGNC-UCL
ATP metabolic process Source: BHF-UCL
Cardiac muscle contraction Source: BHF-UCL
Cardiac muscle hypertrophy in response to stress Source: Ensembl
Muscle contraction Source: HGNC-UCL
Muscle filament sliding Source: HGNC-UCL
Regulation of heart rate Source: HGNC-UCL
Regulation of slow-twitch skeletal muscle fiber contraction Source: BHF-UCL
Regulation of the force of heart contraction Source: BHF-UCL
Regulation of the force of skeletal muscle contraction Source: BHF-UCL
Skeletal muscle contraction Source: BHF-UCL
Striated muscle contraction Source: BHF-UCL
Transition between fast and slow fiber Source: Ensembl
Ventricular cardiac muscle tissue morphogenesis Source: HGNC-UCL
Cellular Location
Other locations
myofibril
sarcomere
Note: Thick filaments of the myofibrils.
Involvement in disease
Cardiomyopathy, familial hypertrophic 1 (CMH1):
A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Myopathy, myosin storage, autosomal dominant (MSMA):
A rare congenital myopathy characterized by subsarcolemmal hyalinized bodies in type 1 muscle fibers.
Scapuloperoneal myopathy MYH7-related (SPMM):
Progressive muscular atrophia beginning in the lower legs and affecting the shoulder region earlier and more severely than distal arm.
Cardiomyopathy, dilated 1S (CMD1S):
A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
Myopathy, distal, 1 (MPD1):
A muscular disorder characterized by early-onset selective weakness of the great toe and ankle dorsiflexors, followed by weakness of the finger extensors. Mild proximal weakness occasionally develops years later after the onset of the disease.
Myopathy, myosin storage, autosomal recessive (MSMB):
An autosomal recessive form of myosin storage myopathy, a muscle disease characterized by subsarcolemmal accumulation of hyalinized bodies in type 1 muscle fibers. MSMB clinical features include muscle weakness, type II respiratory failure and cardiac failure, due to hypertrophic cardiomyopathy.
Left ventricular non-compaction 5 (LVNC5):
A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC5 is an autosomal dominant condition.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-MYH7 Recombinant Antibody (CBYY-C2698)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare